Global Urinary System Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 125 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Urinary System Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Urinary System Drugs market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Urinary System Drugs market by by Loop diuretics, by Thiazide diuretic, by Thiazide-like diuretics, by potassium-sparing diuretics, by Vasopressin receptor antagonist, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Urinary System Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    ALVOGEN MALTA
    APOTEX INC
    ARBOR PHARMS LLC
    ASTRAZENECA
    ATHENEX INC
    BARR
    CLARIS
    DAIICHI SANKYO
    DR REDDYS LABS LTD
    EDENBRIDGE PHARMS
    FRESENIUS KABI USA
    GD SEARLE LLC
    HOSPIRA
    IPCA LABS LTD
    IVAX SUB TEVA PHARMS
    LUPIN LTD
    MACLEODS PHARMS LTD
    MERCK SHARP DOHME
    MYLAN
    PAR PHARM INC
    PFIZER PHARMS
    PRINSTON INC
    SANDOZ
    SANOFI AVENTIS US
    SUN PHARM INDS INC
    TEVA PHARMS
    TORRENT PHARMS LTD
    WATSON LABS
    WEST-WARD PHARMS INT
    WOCKHARDT

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Urinary System Drugs Market, by Loop diuretics
    Furosemide
    Bumetanide
    Bumetanide
    Ethacrynic Acid
    Etozolin
    Muzolimine
    Piretanide
    Ticrynafen
    Torasemide
Urinary System Drugs Market, by Thiazide diuretic
    Hydrochlorothiazide
    Bendrofluazide
    Hdyroflumethiazide
    Polythiazide
    Trichlormethiazide
    Cyclopenthiazide
    Methyclothiazide
    Cyclothiazide
    Mebutizide
Urinary System Drugs Market, by Thiazide-like diuretics
    Quinethazone
    Clopamide
    Chlorthalidone
    Mefruside
    Clofenamide
    Metolazone
    Meticrane
    Xipamide
    Indapamide
    Clorexolone
    Fenquizone
Urinary System Drugs Market, by potassium-sparing diuretics
    Amiloride
    Triamterene
    Spironolactone
    Eplerenone
    Canrenoate Potassium
    Canrenone
Urinary System Drugs Market, by Vasopressin receptor antagoni
    Conivaptan
    Mozavaptan
    Tolvaptan
    Demeclocycline
Main Applications
    Urology Surgery
    department of nephropathy
    Liver disease division
    Hospital
    Clinic

 Table of Contents

Global Urinary System Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two Urinary System Drugs Market Overview
    2.1 Market Coverage
    2.2 Global Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Urinary System Drugs by Key Players 2012-2017
    3.1 Global Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017
    3.2 Global Urinary System Drugs Revenue Share by Key Players 2012-2017
    3.3 Global Key Players Urinary System Drugs Key Product Model and Market Performance
    3.4 Global Key Players Urinary System Drugs Key Target Consumers and Market Performance

Chapter Four Urinary System Drugs by Regions 2012-2017
    4.1 Global Urinary System Drugs Sales Market Share by Regions 2012-2017
    4.2 Global Urinary System Drugs Revenue Market Share by Regions 2012-2017
    4.3 Global Urinary System Drugs Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five Urinary System Drugs Market by Product Types
    5.1 Urinary System Drugs, by Loop diuretics 2012-2017
        5.1.1 Global Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
        5.1.2 Global Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
        5.1.3 Global Urinary System Drugs Price by Loop diuretics 2012-2017
        5.1.4 Furosemide
        5.1.5 Bumetanide
        5.1.6 Bumetanide
        5.1.7 Ethacrynic Acid
        5.1.8 Etozolin
    5.2 Urinary System Drugs, by Thiazide diuretic 2012-2017
        5.2.1 Global Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
        5.2.2 Global Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
        5.2.3 Global Urinary System Drugs Price by Thiazide diuretic 2012-2017
        5.2.4 Hydrochlorothiazide
        5.2.5 Bendrofluazide
        5.2.6 Hdyroflumethiazide
        5.2.7 Polythiazide
        5.2.8 Trichlormethiazide
    5.3 Urinary System Drugs, by Thiazide-like diuretics 2012-2017
        5.3.1 Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
        5.3.2 Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
        5.3.3 Global Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
        5.3.4 Quinethazone
        5.3.5 Clopamide
        5.3.6 Chlorthalidone
        5.3.7 Mefruside
        5.3.8 Clofenamide
    5.4 Urinary System Drugs, by potassium-sparing diuretics 2012-2017
        5.4.1 Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
        5.4.2 Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
        5.4.3 Global Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
        5.4.4 Amiloride
        5.4.5 Triamterene
        5.4.6 Spironolactone
        5.4.7 Eplerenone
        5.4.8 Canrenoate Potassium
    5.5 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
        5.5.1 Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
        5.5.2 Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
        5.5.3 Global Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
        5.5.4 Conivaptan
        5.5.5 Mozavaptan
        5.5.6 Tolvaptan
        5.5.7 Demeclocycline

Chapter Six Global Key Players Profile
    6.1 ALVOGEN MALTA
        6.1.1 ALVOGEN MALTA Company Details and Competitors
        6.1.2 ALVOGEN MALTA Key Urinary System Drugs Models and Performance
        6.1.3 ALVOGEN MALTA Urinary System Drugs Business SWOT Analysis and Forecast
        6.1.4 ALVOGEN MALTA Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.2 APOTEX INC
        6.2.1 APOTEX INC Company Details and Competitors
        6.2.2 APOTEX INC Key Urinary System Drugs Models and Performance
        6.2.3 APOTEX INC Urinary System Drugs Business SWOT Analysis and Forecast
        6.2.4 APOTEX INC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.3 ARBOR PHARMS LLC
        6.3.1 ARBOR PHARMS LLC Company Details and Competitors
        6.3.2 ARBOR PHARMS LLC Key Urinary System Drugs Models and Performance
        6.3.3 ARBOR PHARMS LLC Urinary System Drugs Business SWOT Analysis and Forecast
        6.3.4 ARBOR PHARMS LLC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.4 ASTRAZENECA
        6.4.1 ASTRAZENECA Company Details and Competitors
        6.4.2 ASTRAZENECA Key Urinary System Drugs Models and Performance
        6.4.3 ASTRAZENECA Urinary System Drugs Business SWOT Analysis and Forecast
        6.4.4 ASTRAZENECA Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.5 ATHENEX INC
        6.5.1 ATHENEX INC Company Details and Competitors
        6.5.2 ATHENEX INC Key Urinary System Drugs Models and Performance
        6.5.3 ATHENEX INC Urinary System Drugs Business SWOT Analysis and Forecast
        6.5.4 ATHENEX INC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.6 BARR
        6.6.1 BARR Company Details and Competitors
        6.6.2 BARR Key Urinary System Drugs Models and Performance
        6.6.3 BARR Urinary System Drugs Business SWOT Analysis and Forecast
        6.6.4 BARR Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.7 CLARIS
        6.7.1 CLARIS Company Details and Competitors
        6.7.2 CLARIS Key Urinary System Drugs Models and Performance
        6.7.3 CLARIS Urinary System Drugs Business SWOT Analysis and Forecast
        6.7.4 CLARIS Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.8 DAIICHI SANKYO
        6.8.1 DAIICHI SANKYO Company Details and Competitors
        6.8.2 DAIICHI SANKYO Key Urinary System Drugs Models and Performance
        6.8.3 DAIICHI SANKYO Urinary System Drugs Business SWOT Analysis and Forecast
        6.8.4 DAIICHI SANKYO Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.9 DR REDDYS LABS LTD
        6.9.1 DR REDDYS LABS LTD Company Details and Competitors
        6.9.2 DR REDDYS LABS LTD Key Urinary System Drugs Models and Performance
        6.9.3 DR REDDYS LABS LTD Urinary System Drugs Business SWOT Analysis and Forecast
        6.9.4 DR REDDYS LABS LTD Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.10 EDENBRIDGE PHARMS
        6.10.1 EDENBRIDGE PHARMS Company Details and Competitors
        6.10.2 EDENBRIDGE PHARMS Key Urinary System Drugs Models and Performance
        6.10.3 EDENBRIDGE PHARMS Urinary System Drugs Business SWOT Analysis and Forecast
        6.10.4 EDENBRIDGE PHARMS Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.11 FRESENIUS KABI USA
    6.12 GD SEARLE LLC
    6.13 HOSPIRA
    6.14 IPCA LABS LTD
    6.15 IVAX SUB TEVA PHARMS
    6.16 LUPIN LTD
    6.17 MACLEODS PHARMS LTD
    6.18 MERCK SHARP DOHME
    6.19 MYLAN
    6.20 PAR PHARM INC
    6.21 PFIZER PHARMS
    6.22 PRINSTON INC
    6.23 SANDOZ
    6.24 SANOFI AVENTIS US
    6.25 SUN PHARM INDS INC
    6.26 TEVA PHARMS
    6.27 TORRENT PHARMS LTD
    6.28 WATSON LABS
    6.29 WEST-WARD PHARMS INT
    6.30 WOCKHARDT

Chapter Seven Urinary System Drugs by Appliance 2012-2017
    7.1 Global Urinary System Drugs Sales Market Share by Appliance 2012-2017
    7.2 Urology Surgery
    7.3 department of nephropathy
    7.4 Liver disease division
    7.5 Hospital
    7.6 Clinic
    7.7 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 Urinary System Drugs Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 Urinary System Drugs Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global Urinary System Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
    9.3 Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
    9.4 Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
    9.5 Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
    9.6 Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
    9.7 Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
    9.8 Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
    Table Global Urinary System Drugs Sales Volume () by Key Players (2012-2017)
    Table Global Urinary System Drugs Sales Volume Market Share by Key Players (2012-2017)
    Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2016
    Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2017
    Table Global Urinary System Drugs Revenue (Million USD) by Key Players (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by Key Players (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by Key Players 2016
    Figure Global Urinary System Drugs Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global Urinary System Drugs Sales () by Regions (2012-2017)
    Table Global Urinary System Drugs Sales Share by Regions (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Regions in 2016
    Figure Global Urinary System Drugs Sales Market Share by Regions in 2017
    Table Global Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by Regions (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by Regions in 2016
    Figure Global Urinary System Drugs Revenue Market Share by Regions in 2017
    Table Global Urinary System Drugs Price () by Regions (2012-2017)
    Table North America Urinary System Drugs Sales () by Regions (2012-2017)
    Table North America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
    Table North America Urinary System Drugs Sales Volume () by Key Players 2012-2017
    Figure North America Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Latin America Urinary System Drugs Sales () by Regions (2012-2017)
    Table Latin America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Latin America Urinary System Drugs Sales Volume () by Key Players (2012-2017)
    Figure Latin America Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Europe Urinary System Drugs Sales () by Regions (2012-2017)
    Table Europe Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Europe Urinary System Drugs Sales Volume () by Key Players (2012-2017)
    Figure Europe Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Urinary System Drugs Sales () by Regions (2012-2017)
    Table Asia & Pacific Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific Urinary System Drugs Sales Volume () by Key Players (2012-2017)
    Figure Asia & Pacific Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Urinary System Drugs Sales () by Regions (2012-2017)
    Table Africa & Middle East Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East Urinary System Drugs Sales Volume () by Key Players (2012-2017)
    Figure Africa & Middle East Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Global Urinary System Drugs Sales () by Loop diuretics (2012-2017)
    Table Global Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Loop diuretics in 2016
    Table Global Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
    Table Global Urinary System Drugs Price () by Loop diuretics (2012-2017)
    Table Top Players of Furosemide Urinary System Drugs Products List
    Figure Global Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Bumetanide Urinary System Drugs Products List
    Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Bumetanide Urinary System Drugs Products List
    Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Ethacrynic Acid Urinary System Drugs Products List
    Figure Global Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Etozolin Urinary System Drugs Products List
    Figure Global Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Global Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
    Table Global Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
    Table Global Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
    Table Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
    Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List
    Figure Global Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Bendrofluazide Urinary System Drugs Products List
    Figure Global Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List
    Figure Global Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Polythiazide Urinary System Drugs Products List
    Figure Global Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Trichlormethiazide Urinary System Drugs Products List
    Figure Global Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Global Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
    Table Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
    Table Global Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
    Table Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
    Table Top Players of Quinethazone Urinary System Drugs Products List
    Figure Global Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Clopamide Urinary System Drugs Products List
    Figure Global Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Chlorthalidone Urinary System Drugs Products List
    Figure Global Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Mefruside Urinary System Drugs Products List
    Figure Global Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Clofenamide Urinary System Drugs Products List
    Figure Global Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Global Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
    Table Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
    Table Global Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
    Table Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
    Table Top Players of Amiloride Urinary System Drugs Products List
    Figure Global Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Triamterene Urinary System Drugs Products List
    Figure Global Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Spironolactone Urinary System Drugs Products List
    Figure Global Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Eplerenone Urinary System Drugs Products List
    Figure Global Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Canrenoate Potassium Urinary System Drugs Products List
    Figure Global Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Global Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
    Table Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
    Table Global Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
    Table Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
    Figure Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
    Table Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
    Table Top Players of Conivaptan Urinary System Drugs Products List
    Figure Global Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Mozavaptan Urinary System Drugs Products List
    Figure Global Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Tolvaptan Urinary System Drugs Products List
    Figure Global Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Demeclocycline Urinary System Drugs Products List
    Figure Global Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Table ALVOGEN MALTA Company Details and Competitors
    Table ALVOGEN MALTA Key Urinary System Drugs Models and Performance
    Table ALVOGEN MALTA Urinary System Drugs Business SWOT Analysis and Forecast
    Table ALVOGEN MALTA Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ALVOGEN MALTA Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ALVOGEN MALTA Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure ALVOGEN MALTA Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ALVOGEN MALTA Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table APOTEX INC Company Details and Competitors
    Table APOTEX INC Key Urinary System Drugs Models and Performance
    Table APOTEX INC Urinary System Drugs Business SWOT Analysis and Forecast
    Table APOTEX INC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure APOTEX INC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure APOTEX INC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure APOTEX INC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure APOTEX INC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table ARBOR PHARMS LLC Company Details and Competitors
    Table ARBOR PHARMS LLC Key Urinary System Drugs Models and Performance
    Table ARBOR PHARMS LLC Urinary System Drugs Business SWOT Analysis and Forecast
    Table ARBOR PHARMS LLC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ARBOR PHARMS LLC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ARBOR PHARMS LLC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure ARBOR PHARMS LLC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ARBOR PHARMS LLC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table ASTRAZENECA Company Details and Competitors
    Table ASTRAZENECA Key Urinary System Drugs Models and Performance
    Table ASTRAZENECA Urinary System Drugs Business SWOT Analysis and Forecast
    Table ASTRAZENECA Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ASTRAZENECA Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ASTRAZENECA Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure ASTRAZENECA Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ASTRAZENECA Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table ATHENEX INC Company Details and Competitors
    Table ATHENEX INC Key Urinary System Drugs Models and Performance
    Table ATHENEX INC Urinary System Drugs Business SWOT Analysis and Forecast
    Table ATHENEX INC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ATHENEX INC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ATHENEX INC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure ATHENEX INC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ATHENEX INC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table BARR Company Details and Competitors
    Table BARR Key Urinary System Drugs Models and Performance
    Table BARR Urinary System Drugs Business SWOT Analysis and Forecast
    Table BARR Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BARR Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BARR Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure BARR Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BARR Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table CLARIS Company Details and Competitors
    Table CLARIS Key Urinary System Drugs Models and Performance
    Table CLARIS Urinary System Drugs Business SWOT Analysis and Forecast
    Table CLARIS Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CLARIS Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CLARIS Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure CLARIS Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CLARIS Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table DAIICHI SANKYO Company Details and Competitors
    Table DAIICHI SANKYO Key Urinary System Drugs Models and Performance
    Table DAIICHI SANKYO Urinary System Drugs Business SWOT Analysis and Forecast
    Table DAIICHI SANKYO Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure DAIICHI SANKYO Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure DAIICHI SANKYO Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure DAIICHI SANKYO Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure DAIICHI SANKYO Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table DR REDDYS LABS LTD Company Details and Competitors
    Table DR REDDYS LABS LTD Key Urinary System Drugs Models and Performance
    Table DR REDDYS LABS LTD Urinary System Drugs Business SWOT Analysis and Forecast
    Table DR REDDYS LABS LTD Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure DR REDDYS LABS LTD Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure DR REDDYS LABS LTD Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure DR REDDYS LABS LTD Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure DR REDDYS LABS LTD Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table EDENBRIDGE PHARMS Company Details and Competitors
    Table EDENBRIDGE PHARMS Key Urinary System Drugs Models and Performance
    Table EDENBRIDGE PHARMS Urinary System Drugs Business SWOT Analysis and Forecast
    Table EDENBRIDGE PHARMS Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure EDENBRIDGE PHARMS Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure EDENBRIDGE PHARMS Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
    Figure EDENBRIDGE PHARMS Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure EDENBRIDGE PHARMS Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
    Table FRESENIUS KABI USA Company Details and Competitors
    Table GD SEARLE LLC Company Details and Competitors
    Table HOSPIRA Company Details and Competitors
    Table IPCA LABS LTD Company Details and Competitors
    Table IVAX SUB TEVA PHARMS Company Details and Competitors
    Table LUPIN LTD Company Details and Competitors
    Table MACLEODS PHARMS LTD Company Details and Competitors
    Table MERCK SHARP DOHME Company Details and Competitors
    Table MYLAN Company Details and Competitors
    Table PAR PHARM INC Company Details and Competitors
    Table PFIZER PHARMS Company Details and Competitors
    Table PRINSTON INC Company Details and Competitors
    Table SANDOZ Company Details and Competitors
    Table SANOFI AVENTIS US Company Details and Competitors
    Table SUN PHARM INDS INC Company Details and Competitors
    Table TEVA PHARMS Company Details and Competitors
    Table TORRENT PHARMS LTD Company Details and Competitors
    Table WATSON LABS Company Details and Competitors
    Table WEST-WARD PHARMS INT Company Details and Competitors
    Table WOCKHARDT Company Details and Competitors
    Table Global Urinary System Drugs Sales () by Appliance (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Appliance (2012-2017)
    Figure Global Urinary System Drugs Sales Market Share by Appliance in 2016
    Figure Global Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Figure Global department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Figure Global Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Figure Global Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Figure Global Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
    Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)
    Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
    Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions in 2022
    Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application in 2022
    Table Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
    Figure Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Loop diuretics in 2022
    Table Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
    Figure Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Thiazide diuretic in 2022
    Table Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
    Figure Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Thiazide-like diuretics in 2022
    Table Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
    Figure Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by potassium-sparing diuretics in 2022
    Table Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
    Figure Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)
    Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Vasopressin receptor antagonis in 2022